BDBM476403 4-(aminomethyl)naphthalen-1-yl (3S)- 4-[N-(2-benzyl-2-azaspiro[4.5]dec-8- yl)-3-cyclohexyl-D-alanyl]-3- [(thiophen-2- ylmethyl)carbamoyl]piperazine-1- carboxylate::US10875851, Example 59

SMILES NCc1ccc(OC(=O)N2CCN(C(=O)[C@@H](CC3CCCCC3)NC3CCC4(CC3)CCN(Cc3ccccc3)C4)[C@H](C(=O)NCc3cccs3)C2)c2ccccc12

InChI Key InChIKey=JQUIAODRUQJWEM-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 476403   

TargetCoagulation factor XII(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 476403BDBM476403(4-(aminomethyl)naphthalen-1-yl (3S)- 4-[N-(2-benzy...)
Affinity DataIC50: 4.60nMAssay Description:The effectiveness of a compound of the present invention as an inhibitor of Coagulation Factor XIIa can be determined using a relevant purified serin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
US Patent